James B. Renacci bought China Pharma Holdings Inc (NYSE MKT: CPHI)
James B. Renacci (R-OH), a U.S. Representative, has disclosed 1 trade in China Pharma Holdings Inc (CPHI) since 2016, a single purchase, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: James B. Renacci bought $1,000 - $15,000 of China Pharma Holdings Inc (NYSE MKT: CPHI) on October 5, 2016. Since that trade, CPHI is down -94.18% against the S&P 500 up +300.75%, an outperformance of -394.93%.
Data updated
James B. Renacci's CPHI trades vs the price
CPHI is down -94.18% since James B. Renacci bought on October 5, 2016, versus +300.75% for the S&P 500.
Performance since this trade
All James B. Renacci CPHI trades
James B. Renacci & CPHI trading FAQ
Is it legal for James B. Renacci to trade China Pharma Holdings Inc (CPHI) stock?
Yes. Members of Congress are allowed to trade individual stocks, including China Pharma Holdings Inc (CPHI), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did James B. Renacci buy CPHI?
James B. Renacci disclosed a purchase of $1,000 - $15,000 of China Pharma Holdings Inc (CPHI) on October 5, 2016, according to public STOCK Act filings.
How has CPHI performed since James B. Renacci's trade?
Since James B. Renacci bought CPHI on October 5, 2016, the stock is down -94.18%, versus +300.75% for the S&P 500 over the same period, an outperformance of -394.93%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional CPHI trades?
Quantellect tracks every disclosed congressional trade in China Pharma Holdings Inc (CPHI) on the China Pharma Holdings Inc congressional trading page, which aggregates filings across all members of Congress.
James B. Renacci's CPHI tradesAll congressional filings for China Pharma Holdings IncJames B. Renacci's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.